Detroit Tigers legend Kirk Gibson will be joined by members of the Kirk Gibson Foundation for Parkinson’s Board of Directors ...

The Sanofi equity investment means the Big Pharma will receive exclusive rights of first negotiation surrounding VTX3232, an ...

Sanofi invests $27 million in Ventyx Biosciences at $3.8243 per share. The investment will fund VTX3232 trials for Parkinson's disease.

BOSTON, Sept. 23, 2024 (GLOBE NEWSWIRE) -- Cerevance, a company focused on developing precision novel therapeutics for central nervous system (CNS) diseases, announced that Craig Thompson, chief ...

A study using a tiny roundworm could pave the way for new treatments for neurodegenerative disorders. Researchers linked the worm gene swip-10 to copper regulation -- a vital element for brain health ...

In connection with the equity investment, the Company has agreed to grant Sanofi an exclusive right of first negotiation with respect to certain VTX3232 program rights.

“Our discovery of RORB for these selectively vulnerable cells gives us the opportunity to study in detail exactly why they ...

The FBC Fitness Rock Steady Boxing program has been shown to benefit people with Parkinson's disease, the fitness center's director told last week's weekly meeting of Hot Springs National Park Rotary ...

A first-of-its-kind study will use ultrasound and light therapies to investigate targeted treatment of Alzheimer’s disease, ...

Parkinson's disease (PD) affects about 2% of people aged 70 and older. Over the next 20 years, the number of individuals with ...

Exercise is known as one of the best weapons in limiting the effects of the disease and creating dopamine that is low for ...

Higher exposure to air pollution increases the risk for Parkinson's disease (PD), according to a study published online Sept.